Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer

Diseases of the Esophagus

Volumn 20, Issue 1, 2007, Pages 29-35

  Morgan, M A ^a   Lewis, Wyn G ^a   Hopper, A N ^a   Escofet, X ^a   Harvard, T J ^b   Brewster, A E ^c   Crosby, T D L ^c   Roberts, S A ^a   Clark, G W B ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b ROYAL GLAMORGAN HOSPITAL   (United Kingdom)

^c VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

Body mass index; Esophageal cancer; Surgery

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL TYPE; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; SQUAMOUS CELL CARCINOMA; SURGICAL RISK; SURVIVAL TIME; WESTERN HEMISPHERE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33846206334     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00637.x     Document Type: Article

References (26)

1. CRC (Cancer Research Campaign). Cancer Stats Mortality -UK. London, England: Cancer Research Campaign, 1999.
2. Adams J P, Murphy P G. Obesity in anaesthesia and intensive care. Br J Anaesth 2000; 85: 91-108.
3. Nomura A, Heilbrun L K, Stemmermann G N. Body mass index as a predictor of cancer in men. J Natl Cancer Inst 1985; 74: 319-23.
4. Boyd N F, Campbell J E, Germanson T, Thomson D B, Sutherland D J, Meakin J W. Body weight and prognosis in breast cancer. J Natl Cancer Inst 1981; 67: 785-9.
5. Hansson L E, Baron J, Nyren O et al. Early-life risk indicators of gastric cancer. A population-based case-control study in Sweden. Int J Cancer 1994; 57: 32-7.
6. Dhar D K, Kubota H, Tachibana M et al. Body Mass Index Determines the Success of Lymph Node Dissection and Predicts the Outcome of Gastric Carcinoma Patients. Oncology 2000; 59: 19-23.
7. Cuschieri A, Fayers P, Fielding J et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial. Lancet 1996; 347: 995-9.
8. Bonenkamp J J, Songun I, Herman J et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345: 745-8.
9. Barry J D, Blackshaw G, Lewis W G et al. Western body mass indices need not preclude lymphadenectomy or influence outcomes after modified D2 gastrectomy for carcinoma. Gastric Cancer 2003; 62: 80-5.
10. Welsh Index of Multiple Deprivation [online] http://www.wales.gov.uk/ keypubstatisticsforwales/content/publication/social/2000/deprivation/ intro_e.htm [accessed 5.3.2004].
11. Orringer M B. Transhiatal oesophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg 1984; 200: 282-8.
12. Lewis I. The surgical treatment of carcinoma of the oesophagus, with special reference to new operation for growths of middle third. Br J Surg 1946; 34: 18-31.
13. Tanner I C. The present position of carcinoma of the oesophagus. Postgrad Med J 1947; 23: 109-39.
14. Kennedy B J. The unified international gastric cancer staging classification. Scand J Gastroenterol 1987; 22: 11-13.
15. Sobin L H, Wittekind C H, eds. UICC TNM Classification of Malignant Tumors, 5th edn. New York, USA: John Wiley and Sons, 1997.
16. World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva: WHO, 1998.
17. Stephens M R, Brewster A E, Lewis W G et al. Multidisciplinary teams are associated with improved outcomes after esophagectomy for carcinoma. Dis Esophagus 2006 (in press).
18. Bancewicz J, Clark P, Smith D et al. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomized controlled trial. Lancet 2002; 9319: 1727-33.
19. Altman D G, ed. Practical Statistics for Medical Research. London, England: Chapman & Hall, 1991.
20. Kaplan E L, Meier P. Non-parametric estimation from incomplete observations. J Am Statistics Assoc 1958; 58: 457-81.
21. Seidell J C, Flegal K M. Assessing obesity: Classification and epidemiology. Br Med Bull 1997; 53: 238-52.
22. Williamson D F. Descriptive epidemiology of body weight and weight change in U.S. adults. Ann Intern Med 1993; 119: 464-649.
23. Baba S, Pan W H, Uesshima H, Ozawa H, Komachi Y, Stamler R. Blood pressure levels, related factors, and hypertension control status of Japanese and Americans. J Hum Hypertens 1991; 5: 317-32.
24. Trivers K F, De Roos A J, Gammon M D et al. Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol 2005; 3: 225-30.
25. Wagner P K, Ramaswamy A, Ruschoff J, Schmitz M P, Rothmund M. Lymph node counts in the upper abdomen. Anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 1991; 78: 825-7.
26. Siewert J R, Bottcher K, Stein H J, Roder J D. Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228: 449-61.